Therapeutic area

Musculoskeletal and connective tissue disorders – page 31

872 clinical trials
359 recruiting
331 conditions
28 countries

Clinical trials in Musculoskeletal and connective tissue disorders

872 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

872 clinical trials

Systemic lupus erythematosus+1

Not yet recruiting

Randomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis

Investigational

Randomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Cenerimod
Sponsor:Viatris Innovation GmbH

Contact Research Centre

Ocular myasthenia

Not yet recruiting

Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

Registered drugNo placebo

Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Rozanolixizumab
Sponsor:UCB Biopharma

Contact Research Centre

Ocular myasthenia

Not yet recruiting

A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

Registered drug

A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Rozanolixizumab
Sponsor:UCB Biopharma

Contact Research Centre

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Sonelokimab
Sponsor:MoonLake Immunotherapeutics AG

Contact Research Centre

Systemic lupus erythematosus

Not yet recruiting

Study of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

Investigational

Study of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Telitacicept
Sponsor:Remegen Co. Ltd.

Contact Research Centre

Osteoarthritis

Not yet recruiting

Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

Registered drug

Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:HIS203-CRM197
Sponsor:Peptinov

Contact Research Centre

Systemic scleroderma+1

Not yet recruiting

Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

Investigational

Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Amlitelimab
Sponsor:Scleroderma Research Foundation

Contact Research Centre

Rheumatoid arthritis

Not yet recruiting

Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

Registered drugNo placebo

Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Etanercept
Sponsor:Mabxience Research S.L.

Contact Research Centre

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Tocilizumab
Sponsor:Dr Reddy's Laboratories Limited

Contact Research Centre

Osteoporosis postmenopausal

Not yet recruiting

Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

Registered drugNo placebo

Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Ascorbic Acid
Sponsor:Curateq Biologics Private Limited

Contact Research Centre

Psoriasis+1

Not yet recruiting

Diagnostic PET/CT Study with [AL[18F]F]FAPI-74 in Psoriasis Patients with Arthralgia for Early Detection of Psoriatic Arthritis

InvestigationalNo placebo

Diagnostic PET/CT Study with [AL[18F]F]FAPI-74 in Psoriasis Patients with Arthralgia for Early Detection of Psoriatic Arthritis

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:[Al[18F]F]Fapi-74
Sponsor:UZ Leuven

Contact Research Centre

Sjogren's syndrome

Not yet recruiting

A Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease

Investigational

A Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease

Investigational

Belgium

Participants:18–64 years · 65+ years
Sponsor:Novartis Pharma AG

Contact Research Centre

Substances studied in this area

The therapies tested most often in Musculoskeletal and connective tissue disorders trials.

Sodium Chloride47 clinical trials Paracetamol32 clinical trials Tocilizumab29 clinical trials Methotrexate26 clinical trials Adalimumab24 clinical trials Rituximab23 clinical trials Cyclophosphamide20 clinical trials Etanercept20 clinical trials Baricitinib17 clinical trials

Musculoskeletal and connective tissue disorders – page 31

Conditions in this area

Clinical trials in Musculoskeletal and connective tissue disorders

872 clinical trials

Systemic lupus erythematosus+1

Randomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis

Ocular myasthenia

Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

Ocular myasthenia

A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

Psoriatic arthropathy

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

Systemic lupus erythematosus

Study of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

Osteoarthritis

Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

Systemic scleroderma+1

Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

Rheumatoid arthritis

Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

Rheumatoid arthritis

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Osteoporosis postmenopausal

Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

Psoriasis+1

Diagnostic PET/CT Study with [AL[18F]F]FAPI-74 in Psoriasis Patients with Arthralgia for Early Detection of Psoriatic Arthritis

Sjogren's syndrome

A Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.